Search results
Results from the WOW.Com Content Network
Autoimmune inner ear disease (AIED) was first defined by Dr. Brian McCabe in a landmark paper describing an autoimmune loss of hearing. [2] The disease results in progressive sensorineural hearing loss (SNHL) that acts bilaterally and asymmetrically, and sometimes affects an individual's vestibular system .
Hearing loss completely recovers in around 35–39% of patients with SSNHL, usually within one to two weeks from onset. [34] Steroid treatment within seven days, a lower initial severity of hearing loss, the absence of vertigo, younger patient age, and a history of cardiovascular disease are all associated with complete hearing recovery. [35]
Antiganglioside antibodies that react to self-gangliosides are found in autoimmune neuropathies. These antibodies were first found to react with cerebellar cells . [ 1 ] These antibodies show highest association with certain forms of Guillain–Barré syndrome .
Autoimmune diseases are very often treated with steroids. [3] Autoimmunity means presence of antibodies or T cells that react with self-protein and is present in all individuals, even in normal health state. It causes autoimmune diseases if self-reactivity can lead to tissue damage. [4]
The technology can uniquely identify a person by analyzing the antibodies in body fluids. A unique, individual set of antibodies, called individual specific autoantibodies (ISA), is found in blood, serum, saliva, urine, semen, perspiration, tears, and body tissues, and the antibodies are not affected by illness, medication, or food/drug intake.
The autoimmune regulator (AIRE) is a protein that in humans is encoded by the AIRE gene. [5] It is a 13 kbp gene on chromosome 21q22.3 that encodes 545 amino acids. [ 6 ] AIRE is a transcription factor expressed in the medulla [ broken anchor ] (inner part) of the thymus .
Autoimmune diseases predominantly begin in adulthood, although they can start at any age. [1] The initial recognition of autoimmune diseases dates back to the early 1900s, and since then, advancements in understanding and management of these conditions have been substantial, though much more is needed to fully unravel their complex etiology and ...
In alloimmunity, the body creates antibodies (called alloantibodies) against the alloantigens, attacking transfused blood, allotransplanted tissue, and even the fetus in some cases. Alloimmune ( isoimmune ) response results in graft rejection , which is manifested as deterioration or complete loss of graft function.